Humboldt Fund is an exclusive synthetic biology venture capital firm that invests in early-stage companies (Pre-Seed, Seed, Series A) focused on replacing industrial inputs with biology-based alternatives. Their strategy centers on applying revolutionary biotechnology to transform sectors such as chemicals, materials, food, and medicine, operating at the intersection of engineering, physical, and life sciences.
50% of their portfolio is in Food & Agriculture. Their most common stage is series-b (50% of deals). Average disclosed round size is $39.6M (across 6 rounds with reported amounts).
Portfolio
6
Fund Size
—
Top Stage
Series B
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
6 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Compound Foods | Seed | $4.5M | Aug 2021 |
| MMeatable | Unknown | $47M | Mar 2021 |
 MycoWorks | Series B | $45M | Nov 2020 |
 Geltor | Series B | $91.3M | Jul 2020 |
 Cellino | Seed | $16M | — |
| FFinless Foods | Series B | $34M | — |
Top Co-Investors
SOSV3 shared
WTT Investment Ltd.2 shared
8VC2 shared
CPT Capital1 shared
Cultivian Sandbox1 shared
iSelect Fund1 shared
Blue Horizon1 shared
RIT Capital Partners1 shared
Pegasus Tech Ventures1 shared
Lowercarbon Capital1 shared
Collaborative Fund1 shared
Maple VC1 shared
GV (Google Ventures)1 shared
Section 321 shared
BlueYard Capital1 shared
Agronomics1 shared
The Engine1 shared
Khosla Ventures1 shared
Hanwha Solutions1 shared
Olive Tree Ventures1 shared
Last updated: 16 April 2026